{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:53:45Z","timestamp":1783511625209,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ijrobp.2012.12.008","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T12:26:08Z","timestamp":1363695968000},"page":"e201-e207","source":"Crossref","is-referenced-by-count":33,"title":["Simultaneous Integrated Boost\u2013Intensity Modulated Radiation Therapy With Concomitant Capecitabine and Mitomycin C for Locally Advanced Anal Carcinoma: A Phase 1 Study"],"prefix":"10.1016","volume":"85","author":[{"given":"Maarten J.","family":"Deenen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Dewit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Boot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos H.","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.M.","family":"Schellens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Cats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2012.12.008_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib5","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib6","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ctrv.2011.02.003","article-title":"Chemotherapy\/chemoradiation in anal cancer: a systematic review","volume":"37","author":"Lim","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0360-3016(01)01510-3","article-title":"The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy","volume":"50","author":"Weber","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib9","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/cncr.25901","article-title":"Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal","volume":"117","author":"Bazan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib10","first-page":"2948","article-title":"X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts","volume":"5","author":"Sawada","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2008.11.007","article-title":"Anatomical bases for the radiological delineation of lymph node areas. Part III: pelvis and lower limbs","volume":"92","author":"Lengel\u00e9","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ijrobp.2006.10.013","article-title":"Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer","volume":"67","author":"Yu","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00003088-200140020-00002","article-title":"Clinical pharmacokinetics of capecitabine","volume":"40","author":"Reigner","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/bmc.1302","article-title":"A new, validated HPLC-MS\/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma","volume":"24","author":"Vainchtein","year":"2010","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib15","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1200\/JCO.2005.04.8322","article-title":"Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy","volume":"24","author":"Ruzzo","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib16","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/bcr1526","article-title":"Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study","volume":"8","author":"Ambrosone","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib17","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1158\/1078-0432.CCR-10-2209","article-title":"Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer","volume":"17","author":"Deenen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib18","first-page":"815","article-title":"Intensity-modulated radiation therapy for anal cancer: toxicity versus outcomes","volume":"24","author":"Zagar","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijrobp.2007.12.012","article-title":"EXTRA\u2014a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer","volume":"72","author":"Glynne-Jones","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.12.008_bib20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ijrobp.2006.11.017","article-title":"Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer","volume":"67","author":"Freedman","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612039041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612039041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T17:09:42Z","timestamp":1715101782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301612039041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0360301612039041"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2012.12.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}